Company: LBTYK
Filing Date: 2025-03-25
Form Type: 10-K/A
Source: 0001570585-25-000097
Chunk: 2

Company: Liberty Global Ltd.
Filing Date: 2025-03-25
Form: 10-K/A
Chunk 2
---
 2025 was: 173,057,058shares of class A common shares, 12,968,658shares of class B common shares and 162,728,947shares of class C common shares .

### DOCUMENTS INCORPORATED BY REFERENCE
Portions of the definitive proxy statement for the Registrant’s 2025 Annual General Meeting of Shareholders are incorporated by reference in Part III of this Form 10-K.

### EXPLANATORY NOTE
On February 18, 2025, Liberty Global Ltd. (the Registrant) filed with the Securities and Exchange Commission its Annual Report on Form 10-K (the Form 10-K) for the year ended December 31, 2024. The Registrant’s independent registered public accounting firm is KPMG LLP, Denver, CO, Auditor Firm ID: 185.

The Registrant is filing this Amendment No. 1 on Form 10-K/A (the Form 10-K/A) to include under Item 15 the consolidated financial statements of its equity investees VMED O2 UK Limited and VodafoneZiggo Group Holding B.V., as required by Rule 3-09 of Regulation S-X. Accordingly, the Registrant hereby amends and replaces in its entirety Item 15 of its Form 10-K.

Except as described above, this Form 10-K/A does not update or modify in any way the disclosures provided in the Registrant's Form 10-K, and does not purport to reflect any information or events subsequent to the February 18, 2025 filing thereof.

# PART IV

## Item 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES
(a) (1) FINANCIAL STATEMENTS

The financial statements required under this Item begin on page II-41 of this Annual Report on Form 10-K.

(a) (2) FINANCIAL STATEMENT SCHEDULES

The financial statement schedules required under this Item are as follows:

| Schedule II - Valuation and Qualifying Accounts                                                                              |     | IV-6  |
| Separate Financial Statements of Subsidiaries Not Consolidated and 50 Percent or Less Owned Persons:                         |     |       |
| VMED O2 UK Limited:                                                                                                          |     |       |
| Independent Auditors’ Report                                                                                                 |     | IV-7  |
| Consolidated Balance Sheets as of December 31, 2024 and 2023                                                                 |     | IV-9  |
| Consolid